Alpha 2.0
Login Register
» Authors » M Vachova

M Vachova

Explore the profile of M Vachova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 278
Followers 0
Related Specialties
Neurology
Pharmacy
Allergy & Immunology
Top 10 Co-Authors
J Svihovec
J Mares
I Novakova
L Honzakova
J ELIS
D Horakova
A Novotna
L STIKA
S Ratcliffe
J STRNADOVA
Published In
Mult Scler Relat Disord
Neoplasma
Cesk Farm
Curr Genet
Allergol Immunopathol (Madr)
Affiliations
Soon will be listed here.
Recent Articles
1.
Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder
Stastna D, Vachova M, Dusek P, Fistravec G, Drahota J, Menkyova I, et al.
Mult Scler Relat Disord . 2024 Mar; 85:105523. PMID: 38452649
Background: AntiCD20 therapy, such as rituximab, ocrelizumab, or ofatumumab, effectively treats patients with multiple sclerosis (pwMS) or neuromyelitis optica spectrum disorder (pwNMOSD) but negatively affects the humoral immune response to...
2.
Factors Affecting the Safety and Effectiveness of Venom Immunotherapy
Arzt-Gradwohl L, Annik Herzog S, Herzog S, Aberer W, Alfaya Arias T, Antolin-Amerigo D, et al.
J Investig Allergol Clin Immunol . 2023 Nov; 35(1):40-49. PMID: 37937715
Background: The safety profile of venom immunotherapy (VIT) is a relevant issue, and considerable differences have been reported in the safety and efficacy of this treatment modality. The primary aim...
3.
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
Horakova D, Rockova P, Jircikova J, Dolezal T, Vachova M, Hradilek P, et al.
Mult Scler Relat Disord . 2019 Aug; 35:196-202. PMID: 31400559
Background: Proper management of multiple sclerosis (MS) requires feedback from clinical practice via registries. Objective: To introduce the Czech national multiple sclerosis registry, ReMuS, and explore the availability and use...
4.
Bronchial inflammation in seasonal allergic rhinitis with or without asthma in relation to natural exposure to pollen allergens
Panzner P, Malkusova I, Vachova M, Liska M, Brodska P, Ruzickova O, et al.
Allergol Immunopathol (Madr) . 2013 Oct; 43(1):3-9. PMID: 24075536
Background: Nasal inflammation in allergic rhinitis enhances bronchial Th2 driven inflammation and development of asthma. We assessed bronchial inflammation induced by natural allergen exposure during pollen season in patients with...
5.
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
Langford R, Mares J, Novotna A, Vachova M, Novakova I, Notcutt W, et al.
J Neurol . 2012 Nov; 260(4):984-97. PMID: 23180178
Central neuropathic pain (CNP) occurs in many multiple sclerosis (MS) patients. The provision of adequate pain relief to these patients can very difficult. Here we report the first phase III...
6.
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, et al.
Eur J Neurol . 2011 Mar; 18(9):1122-31. PMID: 21362108
Background:   Spasticity is a disabling complication of multiple sclerosis, affecting many patients with the condition. We report the first Phase 3 placebo-controlled study of an oral antispasticity agent to use...
7.
Phosphatidylglycerolphosphate synthase encoded by the PEL1/PGS1 gene in Saccharomyces cerevisiae is localized in mitochondria and its expression is regulated by phospholipid precursors
Dzugasova V, Obernauerova M, Horvathova K, Vachova M, Zakova M, Subik J
Curr Genet . 1998 Nov; 34(4):297-302. PMID: 9799363
The PEL1/PGS1 gene of the yeast Saccharomyces cerevisiae is essential for the viability of rho-/rho degrees mutants and the normal cardiolipin content of cells. The PEL1-GFP fusion gene has been...
8.
Transport mechanism of L-[14C]glutamate in cortical slices and synaptosomes of rabbits exposed to brain ischemia and reperfusion
Solyakov L, Dobrota D, Drany O, Vachova M, Machac S, Mezesova V, et al.
Mol Chem Neuropathol . 1995 Jun; 25(2-3):123-34. PMID: 8534315
Changes in the functioning of the glutamatergic system in rabbit brain were studied after partial brain ischemia and reperfusion. In vitro studies were conducted relating to the release of L-[14C]glutamate...
9.
Effects of drug administration in pregnancy on children's school behaviour
STIKA L, ELISOVA K, Honzakova L, Hrochova H, Plechatova H, STRNADOVA J, et al.
Pharm Weekbl Sci . 1990 Dec; 12(6):252-5. PMID: 1982564
Files with prescription data were used to assess possible behavioural changes in children, whose mothers used benzodiazepines or neuroleptic drugs during the second half of their pregnancy. Prescriptions, bearing the...
10.
Cardiovascular drugs in Czechoslovakia--registration and consumption data
Seflova M, Sechser T, STRNADOVA J, Skop B, Vachova M, Svihovec J
Pol J Pharmacol Pharm . 1989 Nov; 41(6):533-7. PMID: 2485903
Data on registration and consumption of cardiovascular drugs in Czechoslovakia were sorted from the computerized Drug Information System (DIS) for a detailed analysis. Cardiovascular drugs (including antiarrhythmics, cardiac glycosides, diuretics,...